Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In a Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), adults with obesity (without type 2 diabetes) who received the highest dose of retatrutide (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks
GLP-1 medications are a breakthrough for weight loss and metabolic healthbut commonly cause digestive side effects that can hinder adherence
Each time you look in the mirror you grab the pooch and wish it werent there
Supporting your wellness is your personal business
US$ 21.31
US$ 20.36
US$ 22.95
US$ 24.51
US$ 20.01
